Difference between revisions of "Polycythemia"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer.'''" to "'''Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.'''") |
Warner-admin (talk | contribs) m (Text replacement - "'''Use of this site is subject to you reading and agreeing with the terms set forth" to "{|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center" | <span style="font-family:Arial; font-size:200%"> Hello!<br> We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br> Please help us by filling it out!<br> '''Link:''' http://j.mp/2BlBaoQ </span> |}<br>'''Use of this site is subject to you reading and agreeing with the terms set forth") |
||
| Line 1: | Line 1: | ||
| − | '''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].''' | + | {|style="width: 100%; border-left:solid 20px #dc143c;border-right:solid 20px #dc143c;border-top:solid 20px #dc143c;border-bottom:solid 20px #dc143c;" align="center" |
| + | | | ||
| + | <span style="font-family:Arial; font-size:200%"> Hello!<br> | ||
| + | We're happy that you've chosen to use HemOnc.org, and hope that you will return often. From now until January 31, we are conducting a survey to learn more about our users and how we can make the site better and more useful.<br> | ||
| + | Please help us by filling it out!<br> | ||
| + | '''Link:''' http://j.mp/2BlBaoQ | ||
| + | </span> | ||
| + | |}<br>'''Use of this site is subject to you reading and agreeing with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]]. If this is your first time visiting, we suggest you read the [[tutorial]].''' | ||
==Initial evaluation== | ==Initial evaluation== | ||
Revision as of 20:22, 30 December 2017
|
Hello! |
Use of this site is subject to you reading and agreeing with the terms set forth in the disclaimer. If this is your first time visiting, we suggest you read the tutorial.
Initial evaluation
May consist of:
- CBC with differential
- Pulse oximetry
- Serum erythropoetin
- JAK2 (V617F, exon 12 mutation)
- Comprehensive metabolic panel (CMP)
- Reticulocyte count
- Iron, total iron binding capacity (TIBC), ferritin
- Clinical history of arterial or venous thromboembolism (VTE), stroke, post-bathing pruritis, facial plethora, headache, fatigue, visual changes
Secondary polycythemia?
- Smoking
- Chronic lung disease
- Obstructive sleep apnea (OSA)
- Carbon monoxide (CO) exposure
- Home heating: natural gas or oil?
- Carbon monoxide detectors?
- Carboxyhemoglobin
- High altitude environments
- Testosterone use
- Erythropoetin use
- Athletic blood doping/transfusions
- Right to left cardiac shunt
- Dehydration/diuretic use
Additional considerations
- Renal ultrasound or other imaging to evaluate for erythropoetin-secreting renal tumor, pheochromocytoma
- Chest x-ray
- Urinalysis
- Family history of high oxygen affinity hemoglobinopathies?
- Cushing's syndrome?
- Congenital polycythemia?